• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同烧结方法对 PLGA 微球中蛋白质的生物活性和释放的影响。

Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres.

机构信息

Orbis Biosciences, 2002 W. 39th Ave., Kansas City, KS 66103, USA.

出版信息

Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):4343-51. doi: 10.1016/j.msec.2013.06.026. Epub 2013 Jun 28.

DOI:10.1016/j.msec.2013.06.026
PMID:23910352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3752427/
Abstract

Macromolecule release from poly(d,l-lactide-co-glycolide) (PLGA) microspheres has been well-characterized, and is a popular approach for delivering bioactive signals from tissue-engineered scaffolds. However, the effect of some processing solvents, sterilization, and mineral incorporation (when used in concert) on long-term release and bioactivity has seldom been addressed. Understanding these effects is of significant importance for microsphere-based scaffolds, given that these scaffolds are becoming increasingly more popular, yet growth factor activity following sintering and/or sterilization is heretofore unknown. The current study evaluated the 6-week release of transforming growth factor (TGF)-β3 and bone morphogenetic protein (BMP)-2 from PLGA and PLGA/hydroxyapatite (HAp) microspheres following exposure to ethanol (EtOH), dense phase carbon dioxide (CO2), or ethylene oxide (EtO). EtO was chosen based on its common use in scaffold sterilization, whereas EtOH and CO2 were chosen given their importance in sintering microspheres together to create scaffolds. Release supernatants were then used in an accelerated cell stimulation study with human bone marrow stromal cells (hBMSCs) with monitoring of gene expression for major chondrogenic and osteogenic markers. Results indicated that in microspheres without HAp, EtOH exposure led to the greatest amount of delivery, while those treated with CO2 delivered the least growth factor. In contrast, formulations with HAp released almost half as much protein, regardless of EtOH or CO2 exposure. Notably, EtO exposure was not found to significantly affect the amount of protein released. Cell stimulation studies demonstrated that eluted protein samples performed similarly to positive controls in PLGA-only formulations, and ambiguously in PLGA/HAp composites. In conclusion, the use of EtOH, subcritical CO2, and EtO in microsphere-based scaffolds may have only slight adverse effects, and possibly even desirable effects in some cases, on protein availability and bioactivity.

摘要

聚(DL-丙交酯-共-乙交酯)(PLGA)微球的大分子释放已得到充分研究,是从组织工程支架中传递生物活性信号的一种常用方法。然而,一些加工溶剂、灭菌和矿物质掺入(当协同使用时)对长期释放和生物活性的影响很少被提及。鉴于这些支架越来越受欢迎,了解这些影响对于基于微球的支架非常重要,但迄今为止,尚不清楚烧结和/或灭菌后生长因子的活性。本研究评估了暴露于乙醇(EtOH)、高密度二氧化碳(CO2)或环氧乙烷(EtO)后,PLGA 和 PLGA/羟基磷灰石(HAp)微球中转化生长因子(TGF)-β3 和骨形态发生蛋白(BMP)-2 的 6 周释放情况。选择 EtO 是基于其在支架灭菌中的常用性,而选择 EtOH 和 CO2 是因为它们在将微球烧结在一起以制造支架方面的重要性。然后将释放的上清液用于人类骨髓基质细胞(hBMSCs)的加速细胞刺激研究,监测主要软骨和成骨标志物的基因表达。结果表明,在没有 HAp 的微球中,EtOH 暴露导致最大量的递送,而 CO2 处理的微球则释放最少的生长因子。相比之下,含有 HAp 的配方无论暴露于 EtOH 还是 CO2,释放的蛋白质几乎少一半。值得注意的是,未发现 EtO 暴露显著影响释放的蛋白质量。细胞刺激研究表明,洗脱的蛋白质样品在仅含 PLGA 的配方中与阳性对照表现相似,而在 PLGA/HAp 复合材料中表现不明确。总之,在基于微球的支架中使用 EtOH、亚临界 CO2 和 EtO 可能仅对蛋白质的可用性和生物活性产生轻微的不利影响,在某些情况下甚至可能产生有利影响。

相似文献

1
Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres.不同烧结方法对 PLGA 微球中蛋白质的生物活性和释放的影响。
Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):4343-51. doi: 10.1016/j.msec.2013.06.026. Epub 2013 Jun 28.
2
Subcritical CO2 sintering of microspheres of different polymeric materials to fabricate scaffolds for tissue engineering.不同高分子材料微球的亚临界 CO2 烧结以制造组织工程支架。
Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):4892-9. doi: 10.1016/j.msec.2013.08.010. Epub 2013 Aug 15.
3
Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering.通过微球递送在生物聚合物支架中形成生长因子梯度用于骨软骨组织工程
J Control Release. 2009 Mar 4;134(2):81-90. doi: 10.1016/j.jconrel.2008.10.021. Epub 2008 Nov 17.
4
Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration.用于骨再生的包裹磷酸三钙和羟基磷灰石的微球基支架。
J Mater Sci Mater Med. 2016 Jul;27(7):121. doi: 10.1007/s10856-016-5734-1. Epub 2016 Jun 7.
5
Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.用于递送BMP-2质粒DNA的PLGA/HAp复合支架的制备与表征
J Control Release. 2007 Jul 16;120(1-2):111-21. doi: 10.1016/j.jconrel.2007.03.018. Epub 2007 Apr 1.
6
Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.用于骨组织工程的缓释载体中体外和体内BMP-2生物活性的保留
Biomaterials. 2008 Aug;29(22):3245-52. doi: 10.1016/j.biomaterials.2008.04.031. Epub 2008 May 9.
7
Prolonged release from PLGA/HAp scaffolds containing drug-loaded PLGA/gelatin composite microspheres.载药 PLGA/明胶复合微球的 PLGA/HAp 支架的药物缓释。
J Mater Sci Mater Med. 2012 Feb;23(2):419-29. doi: 10.1007/s10856-011-4493-2. Epub 2011 Nov 18.
8
Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.复合支架中内源性骨形态发生蛋白-2 或外源性植物分子淫羊藿苷成骨潜力的比较研究:体外功效研究。
Acta Biomater. 2012 Aug;8(8):3128-37. doi: 10.1016/j.actbio.2012.04.030. Epub 2012 Apr 24.
9
Degradation, bioactivity, and osteogenic potential of composites made of PLGA and two different sol-gel bioactive glasses.聚乳酸-乙醇酸共聚物(PLGA)与两种不同溶胶-凝胶生物活性玻璃复合材料的降解、生物活性和成骨潜力。
Ann Biomed Eng. 2011 Aug;39(8):2114-29. doi: 10.1007/s10439-011-0307-4. Epub 2011 Apr 13.
10
Tissue-engineered composite scaffold of poly(lactide-co-glycolide) and hydroxyapatite nanoparticles seeded with autologous mesenchymal stem cells for bone regeneration.自体间充质干细胞种植于聚乳酸-羟基乙酸共聚物和纳米羟基磷灰石复合组织工程支架的骨再生研究
J Zhejiang Univ Sci B. 2017;18(11):963-976. doi: 10.1631/jzus.B1600412.

引用本文的文献

1
PLGA-based long-acting injectable (LAI) formulations.基于聚乳酸-羟基乙酸共聚物的长效注射剂(LAI)制剂。
J Control Release. 2025 Jun 10;382:113758. doi: 10.1016/j.jconrel.2025.113758. Epub 2025 Apr 21.
2
The induction of bone formation by 3D-printed PLGA microsphere scaffolds in a calvarial orthotopic mouse model: a pilot study.3D打印聚乳酸-羟基乙酸共聚物(PLGA)微球支架在颅骨原位小鼠模型中诱导骨形成的初步研究
Front Bioeng Biotechnol. 2024 Oct 25;12:1425469. doi: 10.3389/fbioe.2024.1425469. eCollection 2024.
3
Bioinspired gradient scaffolds for osteochondral tissue engineering.用于骨软骨组织工程的仿生梯度支架
Exploration (Beijing). 2023 Jul 12;3(4):20210043. doi: 10.1002/EXP.20210043. eCollection 2023 Aug.
4
PEOT/PBT Polymeric Pastes to Fabricate Additive Manufactured Scaffolds for Tissue Engineering.用于制造组织工程增材制造支架的PEOT/PBT聚合糊剂
Front Bioeng Biotechnol. 2021 Sep 14;9:704185. doi: 10.3389/fbioe.2021.704185. eCollection 2021.
5
Microsphere-Based Osteochondral Scaffolds Carrying Opposing Gradients Of Decellularized Cartilage And Demineralized Bone Matrix.基于微球的骨软骨支架,携带脱细胞软骨和脱矿骨基质的相反梯度。
ACS Biomater Sci Eng. 2017 Sep 11;3(9):1955-1963. doi: 10.1021/acsbiomaterials.6b00071. Epub 2016 Jun 23.
6
A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology.基于电喷雾技术的尼达尼布高生物利用度和持续释放纳米递药系统。
Int J Nanomedicine. 2018 Dec 10;13:8379-8393. doi: 10.2147/IJN.S181002. eCollection 2018.
7
Microsphere-Based Scaffolds in Regenerative Engineering.再生工程中基于微球的支架
Annu Rev Biomed Eng. 2017 Jun 21;19:135-161. doi: 10.1146/annurev-bioeng-071516-044712.
8
Sterilization techniques for biodegradable scaffolds in tissue engineering applications.用于组织工程应用中可生物降解支架的灭菌技术。
J Tissue Eng. 2016 May 17;7:2041731416648810. doi: 10.1177/2041731416648810. eCollection 2016 Jan-Dec.
9
Poly (lactic acid)-based biomaterials for orthopaedic regenerative engineering.用于骨科再生工程的聚乳酸基生物材料。
Adv Drug Deliv Rev. 2016 Dec 15;107:247-276. doi: 10.1016/j.addr.2016.04.015. Epub 2016 Apr 25.
10
Material characterization of microsphere-based scaffolds with encapsulated raw materials.含封装原料的微球基支架材料特性研究
Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:422-8. doi: 10.1016/j.msec.2016.02.038. Epub 2016 Feb 23.

本文引用的文献

1
Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface.用于有效再生骨软骨界面的材料成分和生长因子的连续梯度。
Tissue Eng Part A. 2011 Nov;17(21-22):2845-55. doi: 10.1089/ten.tea.2011.0135. Epub 2011 Aug 4.
2
Osteochondral interface regeneration of rabbit mandibular condyle with bioactive signal gradients.具有生物活性信号梯度的兔下颌髁突骨软骨界面再生
J Oral Maxillofac Surg. 2011 Jun;69(6):e50-7. doi: 10.1016/j.joms.2010.12.049. Epub 2011 Apr 5.
3
The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: Protein distribution and the glial response.通过在可降解的基于 PEG 的水凝胶内形成的 PLGA 微球向大脑内给予 BDNF 和 GDNF:蛋白分布和神经胶质细胞反应。
J Biomed Mater Res A. 2011 Mar 1;96(3):595-607. doi: 10.1002/jbm.a.33011. Epub 2011 Jan 14.
4
Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.乙醇作为共处理溶剂对 PLGA 微球特性的影响。
Int J Pharm. 2010 Jul 15;394(1-2):99-105. doi: 10.1016/j.ijpharm.2010.05.013. Epub 2010 May 22.
5
Special issue on interfacial bioengineering: bridging the gap from the molecular scale to the macroscale.界面生物工程特刊:弥合从分子尺度到宏观尺度的差距。
Ann Biomed Eng. 2010 Jun;38(6):1937. doi: 10.1007/s10439-010-0055-x.
6
Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals.使用生物活性信号的宏观梯度进行软骨-骨界面组织工程。
Ann Biomed Eng. 2010 Jun;38(6):2167-82. doi: 10.1007/s10439-010-0028-0. Epub 2010 Apr 9.
7
Three-dimensional macroscopic scaffolds with a gradient in stiffness for functional regeneration of interfacial tissues.具有刚度梯度的三维宏观支架,用于界面组织的功能再生。
J Biomed Mater Res A. 2010 Sep 1;94(3):870-6. doi: 10.1002/jbm.a.32765.
8
Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering.通过细胞片层工程构建的体外三维组织的预血管化。
Biomaterials. 2010 May;31(14):3903-9. doi: 10.1016/j.biomaterials.2010.01.105. Epub 2010 Feb 19.
9
A novel nano-composite multi-layered biomaterial for treatment of osteochondral lesions: technique note and an early stability pilot clinical trial.用于治疗骨软骨病变的新型纳米复合多层生物材料:技术说明和早期稳定性初步临床试验。
Injury. 2010 Jul;41(7):693-701. doi: 10.1016/j.injury.2009.11.014. Epub 2009 Dec 24.
10
Osteoinduction of hydroxyapatite/beta-tricalcium phosphate bioceramics in mice with a fractured fibula.羟基磷灰石/β-磷酸三钙生物陶瓷在骨折腓骨小鼠中的成骨诱导作用。
Acta Biomater. 2010 Apr;6(4):1569-74. doi: 10.1016/j.actbio.2009.10.050. Epub 2009 Nov 5.